Skip to main content
Journal cover image

Distribution of HPV genotypes in cervical intraepithelial lesions and cervical cancer in Tanzanian women.

Publication ,  Journal Article
Vidal, AC; Murphy, SK; Hernandez, BY; Vasquez, B; Bartlett, JA; Oneko, O; Mlay, P; Obure, J; Overcash, F; Smith, JS; van der Kolk, M; Hoyo, C
Published in: Infect Agent Cancer
November 14, 2011

BACKGROUND: Infection with human papillomavirus (HPV) is associated with uterine cervical intraepithelial neoplasia (CIN) and invasive cancers (ICC). Approximately 80% of ICC cases are diagnosed in under-developed countries. Vaccine development relies on knowledge of HPV genotypes characteristic of LSIL, HSIL and cancer; however, these genotypes remain poorly characterized in many African countries. To contribute to the characterization of HPV genotypes in Northeastern Tanzania, we recruited 215 women from the Reproductive Health Clinic at Kilimanjaro Christian Medical Centre. Cervical scrapes and biopsies were obtained for cytology and HPV DNA detection. RESULTS: 79 out of 215 (36.7%) enrolled participants tested positive for HPV DNA, with a large proportion being multiple infections (74%). The prevalence of HPV infection increased with lesion grade (14% in controls, 67% in CIN1 cases and 88% in CIN2-3). Among ICC cases, 89% had detectable HPV. Overall, 31 HPV genotypes were detected; the three most common HPV genotypes among ICC were HPV16, 35 and 45. In addition to these genotypes, co-infection with HPV18, 31, 33, 52, 58, 68 and 82 was found in 91% of ICC. Among women with CIN2-3, HPV53, 58 and 84/83 were the most common. HPV35, 45, 53/58/59 were the most common among CIN1 cases. CONCLUSIONS: In women with no evidence of cytological abnormalities, the most prevalent genotypes were HPV58 with HPV16, 35, 52, 66 and 73 occurring equally. Although numerical constraints limit inference, findings that 91% of ICC harbor only a small number of HPV genotypes suggests that prevention efforts including vaccine development or adjuvant screening should focus on these genotypes.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Infect Agent Cancer

DOI

EISSN

1750-9378

Publication Date

November 14, 2011

Volume

6

Issue

1

Start / End Page

20

Location

England

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1108 Medical Microbiology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vidal, A. C., Murphy, S. K., Hernandez, B. Y., Vasquez, B., Bartlett, J. A., Oneko, O., … Hoyo, C. (2011). Distribution of HPV genotypes in cervical intraepithelial lesions and cervical cancer in Tanzanian women. Infect Agent Cancer, 6(1), 20. https://doi.org/10.1186/1750-9378-6-20
Vidal, Adriana C., Susan K. Murphy, Brenda Y. Hernandez, Brandi Vasquez, John A. Bartlett, Olola Oneko, Pendo Mlay, et al. “Distribution of HPV genotypes in cervical intraepithelial lesions and cervical cancer in Tanzanian women.Infect Agent Cancer 6, no. 1 (November 14, 2011): 20. https://doi.org/10.1186/1750-9378-6-20.
Vidal AC, Murphy SK, Hernandez BY, Vasquez B, Bartlett JA, Oneko O, et al. Distribution of HPV genotypes in cervical intraepithelial lesions and cervical cancer in Tanzanian women. Infect Agent Cancer. 2011 Nov 14;6(1):20.
Vidal, Adriana C., et al. “Distribution of HPV genotypes in cervical intraepithelial lesions and cervical cancer in Tanzanian women.Infect Agent Cancer, vol. 6, no. 1, Nov. 2011, p. 20. Pubmed, doi:10.1186/1750-9378-6-20.
Vidal AC, Murphy SK, Hernandez BY, Vasquez B, Bartlett JA, Oneko O, Mlay P, Obure J, Overcash F, Smith JS, van der Kolk M, Hoyo C. Distribution of HPV genotypes in cervical intraepithelial lesions and cervical cancer in Tanzanian women. Infect Agent Cancer. 2011 Nov 14;6(1):20.
Journal cover image

Published In

Infect Agent Cancer

DOI

EISSN

1750-9378

Publication Date

November 14, 2011

Volume

6

Issue

1

Start / End Page

20

Location

England

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1108 Medical Microbiology